Wijdenes J - Search Results

1

Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma.

Jansen PM, van der Pouw Kraan TC, de Jong IW, van Mierlo G, Wijdenes J, Chang AA, Aarden LA, Taylor FB Jr, Hack CE. Jansen PM, et al. Among authors: wijdenes j. Blood. 1996 Jun 15;87(12):5144-51. Blood. 1996. PMID: 8652827 Free article.

2

The release of interleukin-12 in Escherichia coli-induced lethal and sublethal primate sepsis.

Jansen PM, van der Pouw Kraan TC, de Jong IW, van Mierlo G, Wijdenes J, Aarden L, Chang AA, Taylor FB Jr, Hack CE. Jansen PM, et al. Among authors: wijdenes j. Ann N Y Acad Sci. 1996 Oct 31;795:351-3. doi: 10.1111/j.1749-6632.1996.tb52690.x. Ann N Y Acad Sci. 1996. PMID: 8958952 No abstract available.

3

Human IL-13 production is negatively influenced by CD3 engagement. Enhancement of IL-13 production by cyclosporin A.

van der Pouw Kraan TC, Boeije LC, Troon JT, Rutschmann SK, Wijdenes J, Aarden LA. van der Pouw Kraan TC, et al. Among authors: wijdenes j. J Immunol. 1996 Mar 1;156(5):1818-23. J Immunol. 1996. PMID: 8596032

4

Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2.

van der Pouw Kraan TC, Boeije LC, Snijders A, Smeenk RJ, Wijdenes J, Aarden LA. van der Pouw Kraan TC, et al. Among authors: wijdenes j. Ann N Y Acad Sci. 1996 Oct 31;795:147-57. doi: 10.1111/j.1749-6632.1996.tb52663.x. Ann N Y Acad Sci. 1996. PMID: 8958925 No abstract available.

5

Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.

van der Pouw Kraan TC, Boeije LC, Smeenk RJ, Wijdenes J, Aarden LA. van der Pouw Kraan TC, et al. Among authors: wijdenes j. J Exp Med. 1995 Feb 1;181(2):775-9. doi: 10.1084/jem.181.2.775. J Exp Med. 1995. PMID: 7836930 Free PMC article.

6

Influence of CD28 co-stimulation on cytokine production is mainly regulated via interleukin-2.

Kuiper HM, de Jong R, Brouwer M, Lammers K, Wijdenes J, van Lier RA. Kuiper HM, et al. Among authors: wijdenes j. Immunology. 1994 Sep;83(1):38-44. Immunology. 1994. PMID: 7821964 Free PMC article.

7

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

Bataille R, Barlogie B, Lu ZY, Rossi JF, Lavabre-Bertrand T, Beck T, Wijdenes J, Brochier J, Klein B. Bataille R, et al. Among authors: wijdenes j. Blood. 1995 Jul 15;86(2):685-91. Blood. 1995. PMID: 7605999 Free article. Clinical Trial.

8

Circulating interleukin-6 receptor in patients with sepsis syndrome.

Frieling JT, van Deuren M, Wijdenes J, van der Meer JW, Clement C, van der Linden CJ, Sauerwein RW. Frieling JT, et al. Among authors: wijdenes j. J Infect Dis. 1995 Feb;171(2):469-72. doi: 10.1093/infdis/171.2.469. J Infect Dis. 1995. PMID: 7661926 Free article.

9

Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.

Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu ZJ, Morel-Fournier B, Harousseau JL, Bataille R, Rossi JF, Klein B. Lu ZY, et al. Among authors: wijdenes j. Blood. 1995 May 1;85(9):2521-7. Blood. 1995. PMID: 7727780 Free article.

10

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10).

Hervé P, Wijdenes J, Bergerat JP, Bordigoni P, Milpied N, Cahn JY, Clément C, Béliard R, Morel-Fourrier B, Racadot E, et al. Hervé P, et al. Among authors: wijdenes j. Blood. 1990 Feb 15;75(4):1017-23. Blood. 1990. PMID: 2136244 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page